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CD36, an 88kd-adhesion molecule, plays a major role as a scavenging receptor implicated in cellular lipid metabolism. Secretory
mammary epithelium, microvasculature endothelium, adipocytes, smooth muscle cells, and platelets express CD36. In addition,
CD36 expression is signiﬁcantly enhanced in macrophages diﬀerentiating into foam cells. The eﬀect of pathological levels of choles-
terol, as observed in apoE−/−, on vascular CD36 expression is, at this stage, not known. In this study, a quantitative analysis of CD36
transcription and protein expression levels, present in tissues of male C57BL/6 and apolipoprotein-E (apoE) deﬁcient mice was
carried out by Northern and Western blots. Four-week-old animals were fed a chow diet over diﬀerent periods of time (0, 6, 16,
or 20weeks). Immunohistochemistry was used to localize CD36 protein expression in the heart and testis. Results indicate that
CD36 transcription is increased in hearts of apoE deﬁcient animals (100% higher at 6weeks, and 30% higher at 16 and 20weeks)
in comparison to wild type. This was conﬁrmed at the protein level, which showed an increase of at least 100% at 6weeks, and
between 40% to 50% increase at 16 and 20weeks of apoE−/− mice compared to controls. In addition, CD36 transcription levels were
signiﬁcantly increased in testis of apoE animals (at least 100% at 6, 16, and 20weeks) compared to C57BL/6 wild type. Such an
increase was also conﬁrmed at the protein level (65% increase at 16weeks in apoE mice compared to control). Finally, localization
of CD36 protein expression by immunohistochemistry showed that it was expressed in the capillaries of heart and testis endothelial
cells and also at the head of spermatozoid during spermatogenesis. These results indicate that high circulating cholesterol levels, in
apoE deﬁcient mice, signiﬁcantly enhance the expression of CD36 in the heart and testis. Such enhanced CD36 expression might
lead to organ remodeling and/or dysfunction.
INTRODUCTION
CD36, an 88kd highly glycosylated glycoprotein, has a
number of putative ligands including thrombospondin, oxi-
dized low density lipoprotein (OxLDL), collagen and long-
chain fatty acids [1, 2, 3, 4]. A wide variety of cells and
tissues,suchasplatelets,monocytes/macrophages,microvas-
culature endothelial cell, erythrocyte precursors, spleen tis-
sue, smooth muscles, mammary epithelium, and adipocytes
express CD36 [3, 4, 5, 6, 7, 8]. Expression of CD36 in en-
dothelial cells is heterogeneous and is tissue-speciﬁc. Indeed,
endothelial cells lining large arterial vessels or brain capillar-
ies do not stain for CD36 [9, 10]. In contrast, CD36 is highly
expressed in endothelial cells of adipose tissue, diﬀerentiated
mammary epithelial tissue, and cardiac and skeletal muscles
[6, 9, 11]. CD36, also known as fatty acid translocase (FAT)
in rat adipocytes or PASIV in bovine mammary, is a mem-
ber of class B scavenger receptors [4, 12]. CD36 is involved
in the endocytosis of OxLDL and in the phagocytosis, in tan-
dem with αvβ3, of apoptotic neutrophils [2, 13]. In addition,
CD36 is also implicated in the cytoadherence of erythrocytes
infected by Plasmodium falciparum [14].
OxLDLscavengingreceptorsplayacrucialroleintheini-
tiation and perpetuation of vascular lesions [15, 16]. Indeed,
capacity of CD36 to bind and internalize OxLDL is thought
to modulate the diﬀerentiation of macrophages into foam
cells [2, 17, 18, 19]. A region on CD36, encompassing amino
acids155–183,wasidentiﬁedastheOxLDLbindingsite[20].
Nozaki et al showed in monocytes-derived macrophages,
from subjects presenting a deﬁcit in CD36 expression, a
40% reduction in their capacity to accumulate OxLDL [21].
Moreover, a mouse deﬁciency of CD36 in an apoE knock-
out was shown to greatly reduce the size of vascular lesions
[22]. However, such CD36-deﬁcient mice show a high plas-
matic level of cholesterol, nonesteriﬁed free acids and tri-
acylglycerol [23]. The critical role of CD36 in monocytes
diﬀerentiation into macrophages, as shown by Tontonoz et
al and Nagy et al, is linked to its capacity in OxLDL up-
take [24, 25]. OxLDL, via CD36, induces the activation of
peroxisome proliferator-activated receptor γ (PPARγ)a n d
the subsequent lipid accumulation in macrophages [24, 25].
Very little is known on how increased levels of triacyl-
glycerol and total cholesterol, in the circulation of apoE deﬁ-
cient mice, might aﬀect CD36 expression in the vasculature2:1 (2002) Expression of CD36 in apoE Knockout Mice 15
of diﬀerent organs. This study has investigated CD36 expres-
sion in diﬀerent organs and reports, for the ﬁrst time, signif-
icant increased levels of CD36 in the heart and testis of apoE
deﬁcient but not wild-type (C57BL/6) mice.
METHODS
Animalhandling
Surgical procedures and animal care are strictly con-
formed to the Guidelines of the National Institute of Health
andMedicalResearch(DecreeNo.87-848October19,1987).
All animals used in this study were ether anesthetized before
organ sampling.
Mice
The apoEm1Unc line was obtained from Dr N. Maeda
(Chapel Hill, North Carolina University, USA). Control
C57BL/6JIco and apoE deﬁcient mice (C57BL/6JIco back-
ground) were backcrossed, bred, and housed, under speciﬁc
and opportunistic pathogen-free conditions, by Transgenic
Alliance (IﬀaC r e d oS . A . ,L y o n ,F r a n c e ) .B o t hc o n t r o l( n =
48) and apoE deﬁcient mice (n = 48) were weaned at 3weeks
of age and maintained on chow diet for 1week (“Souriﬀarat”
breedingdiet,standardformulation,andpellets,irradiatedat
25kGy, from Extralabo, France). Following that stage, mice
had access to a chow (4% fat, 0% cholesterol) diet and re-
ceived water and food ad libitum during the 0-, 6-, 16-, and
20-week schedules. Control and apoE deﬁcient mice, at the
end of each feeding period, were anesthetized by ether in-
halation. Subsequently the thoracic cavity was opened, the
heart and other organs were removed and sampled. Frag-
ments of tissues were snap frozen in liquid nitrogen, and
stored at −80◦C for later use for molecular and cellular bi-
ology techniques. Tissue fragments were also rapidly em-
bedded in optimal cutting temperature (OCT) compound,
(MilesLaboratoriesInc.,Elkhart,IN,USA)andfrozeninliq-
uid nitrogen for later use for immunohistochemistry.
Cholesterollevelanalysis
It was carried out in the blood collected from the retro-
orbital sinus of anesthetized animals at the end of each ob-
servation period before sacriﬁce. Total cholesterol was deter-
mined using commercially available assay kits (Boehringer
Mannheim, France) and expressed in mmol/L. apoE−/− chow
fed mice showed, at 0weeks of diet, higher plasma choles-
terol levels (9.594 ± 0.624mmol/L), prior to diet feeding, in
comparison to wild type C57BL/6 animals (2.312 ± 0.259).
These signiﬁcant diﬀerences, between both strains, were
maintained at all phases of the experiment. The following
values were obtained for chow fed apoE−/− and C57BL/6
mice at 0, 6, 16, and 20weeks, respectively, [(9.594 ± 0.624,
2.312±0.259);(18.27 ± 3.209, 2.966 ± 0.401);(23.501±3.801,
2.532 ± 0.176); (19.866 ± 2.32, 2.635 ± 0.538mmol/L)].
TotalRNAisolation
TissuesamplesfromC57BL/6andapoE−/− mice(n = 96),
isolated at diﬀerent periods of time (0, 6, 16, 20weeks), were
snap frozen in liquid nitrogen and stored at −80◦C. Total
RNA was extracted from samples (n = 6) at each indicated
time. Brieﬂy, frozen tissues were ground in a mortar in liq-
uid nitrogen. The frozen powdered sample was immediately
mixed with TRIzol (Gibco BRL, Life Technologies) and ho-
mogenized with a Polytron. Total RNA was extracted using
the TRIzol method adapted from the Chomczynski and Sac-
chi procedure [26].
CD36probesynthesisandlabeling
The 693bp CD36 probe was prepared by RT-
PCR. The following primers (CD36-275U19: GAGGA-
GAATGGGCTGTGAT and CD36-948L21: GGACTCAAT-
TATGGCAACTTT) were used for PCR ampliﬁcation.
RT-PCR, labeling and puriﬁcation were done according to
standard techniques.
Northernblot
Total RNA (20µg) was denatured, separated by elec-
trophoresis on a formaldehyde-MOPS-agarose gel and then
transferred to a nylon membrane (Hybond N+, Amer-
sham, UK). After capillary blotting, performed overnight,
the membrane was baked for 2hours at 80◦C. Prehybridiza-
tion and hybridization were done according to standard pro-
tocols [27]. Blots were exposed against a phosphorimager
screen (Molecular Dynamics) for 24hours. Scanning was
done under a 100µ scale and the ImageQuant software was
then used for quantiﬁcation. Variations in RNA loading was
assessed using 28S that allowed normalizing of CD36 values.
All quantiﬁcation values were corrected for background lev-
els using the local median method of the ImageQuant soft-
ware. The initial scan image (gel format) was transferred
into a Tiﬀ ﬁle to allow its presentation in the ﬁgures of the
manuscript.
ProteinpreparationandWesternblot
Hearts and testis maintained in liquid nitrogen were
poundinamortar,thenhomogenizedat0◦C(two10-second
burst) in tris-buﬀered saline containing 1% aprotinin,
2mmol/L ε-aminocaproic acid and 0.5mmol/L phenyl-
methylsulfonyl ﬂuoride. The homogenate was centrifuged at
1000g for 5minutes to remove the unhomogenized frag-
ments. The supernatant was then centrifuged at 100.000g
for 1hour to obtain microsomal (membrane proteins) and
supernatant (cytoplasmic proteins) fractions. The pellets of
microsomal fractions were solubilized in SDS 1%. Micro-
somes were diluted in Laemmli SDS-PAGE lysis buﬀer and
their proteins were separated on 10% acrylamide SDS-PAGE
gels. The proteins were transferred to a nitrocellulose mem-
brane and blocked for 4hours with 10% nonfat milk and
0.05% Tween 20 in tris-buﬀered saline pH 7.5. The CD36
band on Western blots was identiﬁed through the use of a
guineapiganti-mouseCD36(dilution1/1000),followedbya
horseradish peroxidase conjugated goat anti-guinea pig anti-
body (DAKO), and ECL reagents used according to the man-
ufacture’s instructions (Amersham) [28]. ECL ﬁlms were
scanned with Sharp JX-330 scanner (Amersham) and CD3616 Kazem Zibara et al 2:1 (2002)
bands were quantiﬁed with Total Lab Software (Amersham).
In parallel, SDS-PAGE gels, containing identical sample vol-
umes to those used for the Western blot were Coomassie
stained. Electrophoretic bands of 50 and 200kd (for heart
samples) and 50kd (for testis samples) were scanned and
used as a quantitative control to check for sample loading
and CD36 normalization.
Immunohistochemistry
Serial sections (6µm) were generated on a cryostat,
mounted on gelatin coated slides. Immediately before stain-
ing, frozen sections were air dried for 1hour at room tem-
perature (RT), ﬁxed in 100% ice-cold acetone for 5minutes,
andagainairdriedfor15minutes.Sections,originatingfrom
apoE and C57BL6 animals were stained as described below.
Antibodies used were a guinea pig antiserum against murine
CD36 (dilution 1/500) and a non-immune guinea pig serum
(dilution 1/500) used as negative control [28]. Following
acetone ﬁxation and blocking, CD36 was visualized after
incubation with a rabbit anti-guinea pig immunoglobulin
(peroxidase labeled polymer conjugated to goat anti-rabbit
immunoglobulinsand3-amino-9-ethylcarbazole)(EnVision
+ System Peroxidase, Dako, France). A non-immune guinea
pig serum was used at the place of the primary antibodies
as a negative control. Immunostained sections were counter-
stained with hematoxylin.
RESULTS
CD36 mRNA and protein expression were assayed on or-
gans of apoE−/− and C57BL/6 mice fed 0- to 20-week chow
diet, through the use of Northern, Western blots and im-
munohistochemistry techniques. Cholesterol levels for apoE
deﬁcient animals were signiﬁcantly higher than the wild type
at all stages of the protocol (0, 6, 16, and 20weeks, see Meth-
ods section).
mRNAlevelsofCD36indifferenttissues
Northern blots, in C57BL/6 wild-type mice, showed the
presence of CD36 RNA transcripts in the heart, lung, kid-
ney, skeletal muscles, and to a lesser extent in the spleen
(Figure 1a).
The gradient of CD36 gene transcript expression was at
its lowest value in the testis and the highest in the heart. In
contrast, apoE deﬁcient mice showed higher CD36 mRNA
levels in the heart and testis (200% increase), at 6weeks of
chow diet (Figure 1b). It is of interest to note that kidney
CD36mRNAlevelswerealsoincreased.Theseresultssuggest
that three of the tested organs (heart, testis, and kidney) are
aﬀected by high cholesterol and triacylglycerol levels. In this
study, we have focused on the heart and testis tissues since
they showed the highest diﬀerences in mRNA levels between
knockout and wild-type animals.
mRNAandproteinlevelsofCD36intheheart
The hearts of apoE deﬁcient mice presented an increase
in CD36 steady state RNAs, in comparison to wild type,
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(a) Representative northern blot showing transcription levels of CD36
in skeletal muscles (Sk), heart (H), lung (L), liver (Li), spleen (S), kid-
ney (K) and testis (T) of apoE deﬁcient mice, in comparison to wild
type (C57BL/6). Blots contained 20µg of total RNA. A control for
loading and for quantiﬁcation (28S) was also used.
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(b) Quantiﬁcation of CD36 signals reported to control 28S levels.
C57BL/6 is shown in light gray while the apoE is shown in black.
Figure 1. Northern blot analysis of CD36 mRNA levels in diﬀerent tissues.
at 6, 16, and 20weeks of chow diet (Figure 2a). Indeed,
CD36 overexpression was at least 100% higher at 6weeks
and 30% higher at 20weeks in apoE−/− compared to wild-
type mice. It is to be noted that young apoE mice (0weeks
of diet, 4-week-old animals) did not show diﬀerences in
CD36 transcription compared to wild type (Figure 2b). The
hearts of both C57BL/6 and apoE deﬁcient mice contained
not only the usual CD36 mRNA, but also a lower abun-
dant transcript of a lower molecular weight. This second
observed transcript might arise from the use of an al-
ternative polyadenylation site [29]. Results in mRNA lev-
els were conﬁrmed at the protein level by Western blots
(Figure 3a). CD36 heart protein levels showed an increase
of 100% at 3 and 6weeks, and between 40% to 50% at
16 and 20weeks in apoE−/− mice, compared to wild type
(Figure 3b).
mRNAandproteinlevelsofCD36inthetestis
Northern blot shows that CD36 mRNA levels are upreg-
ulated, by at least 100% at 6, 16, and 20weeks of chow diet,
in testis of chow fed apoE−/−, compared to wild type (Fig-
ures 4a and 4b). In contrast, no increase in CD36 mRNA lev-
els were observed in wild-type mice (0- to 20-week chow fed
diet). Moreover, no diﬀerences in CD36 transcription lev-
els were present between 4-week-old apoE−/− and wild-type
mice (0weeks of diet) (Figures 4a and 4b). The CD36 pro-
tein expression levels, in testis of deﬁcient apoE−/− mice, was2:1 (2002) Expression of CD36 in apoE Knockout Mice 17
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(a) Representative Northern blot showing CD36 mRNA expression
in hearts of chow fed apoE−/− mice, in comparison to wild type
(C57BL/6). Blots contained 20µg of total RNA. The 0, 6, 16, and 20
correspond to the number of weeks of chow diet. The 28S expression
served as a control for loading and for quantiﬁcation.
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(b) Quantiﬁcation of heart CD36 signals reported to 28S levels.
C57BL/6 is shown in light gray while the apoE is shown in black.
∗P<. 05 compared to deﬁcient apoE mice.
Figure 2. Northern blot analysis of CD36 mRNA levels in the heart.
signiﬁcantly increased (P<. 05) at 16weeks compared to the
levels observed in wild-type mice (Figures 5a and 5b).
Immunohistochemistry
An anti-CD36 polyclonal antibody stained heart en-
dothelial cells lining arterioles and terminal capillaries (Fig-
ures 6b and 6d). CD36 immunohistochemical distribution
was similar, regardless of the duration of the diet, in the
hearts of apoE−/− and wild-type mice. CD36 in testis was lo-
calized to spermatids and spermatozoids (Figures 6f, 6g, 6i,
and 6j) and to capillary endothelial cells (data not shown).
A non-immune guinea pig serum, used as control, did not
show any speciﬁc labeling (Figures 6a, 6c, 6e,a n d6h).
DISCUSSION
Thisstudyreports,fortheﬁrsttime,asigniﬁcantincrease
inCD36mRNAandproteinexpressionintheheartandtestis
of apoE−/− mice, compared to wild type (C57BL6). Several
lines of evidence back the above statement: (1) Northern
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(a)RepresentativewesternblotofCD36proteinexpressioninheartsof
chow fed apoE−/− mice, in comparison to wild type (C57BL/6). Blots
contained50µgofmembraneproteins.The0,6,16,and20correspond
to the number of weeks of chow diet. A control for loading and quan-
tiﬁcation was also used on the Coomassie gel (not shown).
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(b) Quantiﬁcation of heart CD36 signals reported to a control protein.
C57BL/6 is shown in light gray while apoE is shown in black. ∗P<. 05
compared to deﬁcient apoE mice.
Figure 3. Western blot analysis of CD36 protein levels in the heart.
blots of heart and testis showed CD36 mRNA levels to be sig-
niﬁcantly increased, at 6, 16, and 20weeks in apoE−/−,c o m -
pared to wild type. (2) Likewise, CD36 protein expression
levels in hearts and testis was increased at 6, 16, and 20weeks
in apoE−/−, compared to wild type. (3) Wild-type mice did
not show, between 0 and 20weeks of diet, changes in CD36
mRNA and protein expression levels in the heart or testis.
(4) Finally, immunohistochemistry analysis showed CD36 to
be localized on endothelial cells lining arterioles and termi-
nal capillaries in the heart while it is localized in spermatids,
spermatozoids, and capillary endothelial cells in the testis.
The present study has observed a signiﬁcant upregula-
tion of CD36 in cardiac cells, in apoE deﬁcient animals com-
pared to wild type. Such an increase in heart-CD36 expres-
sion could be related to cell lipid metabolism and to high
cholesterol levels. Indeed, previous work performed on dif-
ferent mice models, (NOD, KKAy, and high fat diet Swiss18 Kazem Zibara et al 2:1 (2002)
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(a) Representative Northern blot showing CD36 mRNA levels in testis
ofchowfedapoE−/− mice,incomparisontowildtype(C57BL/6).Blots
contained 20µg of total RNA. The 0, 6, 16, and 20 correspond to the
number of weeks of chow diet. The 18S expression served as a control
for loading and for quantiﬁcation.
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(b) Quantiﬁcation of testis CD36 signals, reported to 18S control lev-
els. C57BL/6 is shown in light gray while apoE is shown in black.
∗P<. 05 compared to apoE−/− mice.
Figure 4. Northern blot analysis of CD36 mRNA levels in the testis.
Webster),showanupregulationofCD36intheheartofthese
animals that are associated to high level of plasma triglyc-
eride [6]. Moreover, FAT/CD36 overexpression in muscle tis-
sues of transgenic animals enhances cellular fatty acids up-
take and oxidation by contracting muscle and a reduction of
plasma triglycerides [30]. It is of interest to note that cardiac
tissue possesses a high capacity to oxidize large amounts of
long-chain fattyacids (LCFA)[31].Molecules,suchasLCFA,
represent a major heart energy substrate and their oxida-
tion is deemed vital to allow maximal cardiac work. CD36,
known as FAT in rat’s heart muscles, has been shown to
have a sequencehomology to a bovine receptor implicated in
the transport of myocardial LCFA [4, 32]. Recently, the role
of cardiac tissue CD36 was beautifully investigated through
the use of subjects showing an abnormality in CD36 expres-
sion (type I and II CD36 deﬁciency) and their capacity for
myocardial LCFA uptake. The absence of cellular CD36 ex-
pression by platelets or monocytes, as observed in individ-
uals with a type I CD36 deﬁciency, is also observed in my-
ocardial capillary endothelial cells [33]. Several mutations
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(a) Representative western blot showing CD36 protein expression lev-
els in testis of chow fed apoE−/− mice at 16week of diet, in comparison
to wild type (C57BL/6). Blots contained 50µg of puriﬁed membrane
proteins. Three testis samples of diﬀerent apoE−/− and C57BL6 mice
were used. A control for loading and for quantiﬁcation was also used
on the Coomassie gel (not shown).
0
0.5
1
1.5
2
2.5
∗
C
D
3
6
/
c
o
n
t
r
o
l
p
r
o
t
e
i
n
l
e
v
e
l
s
C57BL6 apoE
Testis after 16 weeks of chow diet
(b) Quantiﬁcation of testis CD36 signals reported to a control pro-
tein. C57BL/6 is shown in light gray while the apoE is shown in black.
∗P<. 05 compared to apoE−/− mice at 16weeks of diet.
Figure 5. Western blot analysis of CD36 protein levels in the testis.
(deletion, insertion, and punctual mutation) in the CD36
gene have been identiﬁed in type I deﬁciency [34]. Myocar-
dial capillary endothelial cells, in type I CD36-deﬁcient in-
dividuals, show a lack of myocardial LCFA accumulation
and metabolism in the myocardium [33, 34, 35, 36]. Type
I CD36-deﬁcient individuals are reported to present car-
diac troubles as hereditary hypertrophic cardiomyopathy.
In contrast, in type II CD36 deﬁciency, where the absence
of CD36 expression is only observed in platelets but not
monocytes, the accumulation in the heart of LCFA analog
(BMIPPorbeta-methyl-p-iodophenylpentadecanoicacid)is
reduced but not totally absent, as in type I [33]. It is conceiv-
able, that the up-regulation of CD36 in apoE−/− mice results
from LCFA accumulation and/or enhanced blood viscosity
due to increased cholesterol levels. Increase in heart-vascular2:1 (2002) Expression of CD36 in apoE Knockout Mice 19
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Figure 6. Immunohistochemistry analysis of CD36 in the heart and testis:
CD36 immuno-staining of murine heart and testis at 16weeks of chow diet.
Heart ((b) and (d)), and testis ((f), (g), (i), and (j)) were immuno-stained
through the use of a guinea pig anti-murine CD36 polyclonal antibody.
Heart((a)and(c))andtestis((e)and(h))negativecontrolswereperformed
using a non-immune guinea pig serum. (a), (b), (e), (f), (g) show wild-type
(C57BL/6) hearts or testis. Panels (c), (d), (h), (i), (j) show apoE−/− hearts
o rt e s t i s .M a g n i ﬁ c a t i o n sa r eX 1 0 0f o r( a ) ,( b ) ,( c ) ,( e ) ,( f) ,( h ) ,( i ) ,a n dX 2 5 0
for (g), (j).
CD36 expression could allow the heart to better adapt to its
environment.
Data presented in this study reports, for the ﬁrst time, an
enhanced CD36 mRNA and protein expression in the testis
of apoE deﬁcient mice in comparison to wild type. Abum-
rad et al showed the presence of FAT/CD36 in rat testis [4].
The localization and the function of FAT/CD36 in rat testis
are at this stage unknown. Other scavenger receptors of the
same class as CD36, SR-BI, and SR-BII have been found to be
expressed in testis. In sertoli cells, SR-BI plays an important
role in the phagocytosis of the apoptotic spermatogenic cells
by recognizing phosphatidylserine exposed on the surface of
these cells [37]. Moreover, SR-BI is expressed by another im-
portant cell in testis, Leydig cells, implicated in testosterone
production [38]. Gonadotrophic hormone treatment of rats
induces an increase in SR-BI expression by Leydig cells and a
concomitant reduction in testosterone levels. Moreover, SR-
BI allows Leydig cells to make a selective uptake of choles-
terol ester. Such an uptake of cholesterol ester may presum-
ably allow a renewal of testosterone production. Expression
of scavenger receptor SR-BII by Leydig cells remains negli-
gible and unaﬀected by gonadotrophic hormone treatment
[38]. On analysis of testis CD36 immuno-staining, we were
surprisedtoidentifyCD36expressionattheheadofthesper-
matids and spermatozoids, beside endothelial cell capillar-
ies. The expression of CD36 in endothelial cell is not sur-
prising and could be related to lipid metabolism. However,
the role and function of CD36 in the spermatozoid is still
at this stage unknown. High CD36 expression by spermato-
zoid could be related to the high level of cholesterol, present
in the apoE deﬁcient mice, and be implicated in the sper-
matogenesis process. Several studies indicate the importance
of hypercholesterolaemia in the spermatogenesis and secre-
tory functions of Leydig and Sertoli cells. Yamamoto et al has
shown that hypercholesterolaemia could have a detrimental
eﬀect on Leydig and Sertoli cells secretory functions and the
overall sperm fertilizing capacity [39].Moreover, in apoE de-
ﬁcient mice fed with high cholesterol diet, Moghadasian et
al has shown an arrest of spermatogenesis and the atrophy
of seminiferous tubules [40]. The absence of an enzyme, the
hormone-sensitive lipase (HSL), in an HSL knockout mouse
induces a signiﬁcant reduction of mature spermatids and a
lossofmobilityofspermatozoids[41].Itisinterestingtonote
that HSL, an enzyme that catalyzes the hydrolysis of triacyl-
glycerol, could play an important role in the regulation of
CD36 expression [42, 43, 44, 45]. Taken together, these re-
sults suggest a potential role of CD36 in spermatogenesis.
In conclusion, in this study we have shown that CD36
is signiﬁcantly up-regulated in heart and testis of apoE de-
ﬁcient mice. The heart CD36 up-regulation is related to
parenchymal cell lipid metabolism and in particular to LCFA
uptake.Moreover,increaseinCD36expressionintestis,sper-
matids and spermatozoids may potentially indicate a new,
yet unknown role, for this scavenging receptor in the fertil-
ity mechanism. To elucidate and determine the function and
the importance of CD36 in testis and in the spermatogenesis
process, further investigations would be realized.20 Kazem Zibara et al 2:1 (2002)
ACKNOWLEDGMENTS
This work was supported by the French Ministry of
Education and Scientiﬁc Research (grant MESR ACC-SV9)
and by the European Network on Atherosclerosis (ENA,
BIOMED 2, grant # PL 1195). Eric Malaud was supported
by a PhD fellowship awarded by “la R´ egion Rhˆ one-Alpes.”
We would like to warmly thank Prof Christopher Glass
(Department of Cellular and Molecular Medicine, School
of Medicine, University of California, San Diego, La Jolla,
USA)foragenerousgiftofaguineapiganti-CD36polyclonal
antibody.
REFERENCES
[1] Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isola-
tion of the thrombospondin membrane receptor. JC l i n
Invest. 1987;79:1054–1061.
[2] Endemann G, Stanton LW, Madden KS, Bryant CM,
White RT, Protter AA. CD36 is a receptor for oxidized
lowdensitylipoprotein.JBiolChem.1993;268:221–236.
[3] Tandon NN, Lipsky RH, Burgess WH, Jamieson GA.
Isolation and characterization of platelet glycoprotein
IV (CD36). J Biol Chem. 1989;264:7570–7575.
[4] Abumrad NA, el Maghrabi MR, Amri EZ, Lopez E,
Grimaldi PA. Cloning of a rat adipocyte membrane
protein implicated in binding or transport of long-
chain fatty acids that is induced during preadipocyte
diﬀerentiation. Homology with human CD36. JB i o l
Chem. 1993;268:17665–17668.
[5] Talle MA, Rao PE, Westberg E, et al. Patterns of anti-
genic expression on human monocytes as deﬁned by
monoclonal antibodies. Cell Immunol. 1983;78:83–99.
[6] Greenwalt DE, Scheck SH, Rhinehart-Jones T. Heart
CD36 expression is increased in murine models of di-
abetes and in mice fed a high fat diet. JC l i nI n v e s t .
1995;96:1382–1388.
[7] Edelman P, Vinci G, Villeval JL, et al. A monoclonal an-
tibody against an erythrocyte ontogenic antigen iden-
tiﬁes fetal and adult erythroid progenitors. Blood.
1986;67:56–63.
[8] GreenwaltDE,WattKW,SoOY,JiwaniN.PASIV,anin-
tegral membrane protein of mammary epithelial cells,
is related to platelet and endothelial cell CD36 (GP IV).
Biochemistry. 1990;29:7054–7059.
[9] Greenwalt DE, Mather IH. Characterization of an api-
cally derived epithelial membrane glycoprotein from
bovine milk, which is expressed in capillary endothelia
in diverse tissues. JC e l lB i o l . 1985;100:397–408.
[10] Turner GD, Morrison H, Jones M, et al. An immuno-
histochemical study of the pathology of fatal malaria.
Evidence for widespread endothelial activation and a
potential role for intercellular adhesion molecule-1 in
cerebral sequestration. Am J Pathol. 1994;145:1057–
1069.
[11] KnowlesDM,TolidjianB,MarboeC,D’AgatiV,Grimes
M, Chess L. Monoclonal anti-human monocyte anti-
bodies OKM1 and OKM5 possess distinctive tissue dis-
tributions including diﬀerential reactivity with vascular
endothelium. JI m m u n o l . 1984;132:2170–2173.
[12] Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda
H, Tandon NN, Jamieson GA. Membrane glycopro-
tein CD36: a review of its roles in adherence, sig-
nal transduction, and transfusion medicine. Blood.
1992;80:1105–1115.
[13] NavazoMD,DavietL,SavillJ,RenY,LeungLL,McGre-
gor JL. Identiﬁcation of a domain (155-183) on CD36
implicatedinthephagocytosisofapoptoticneutrophils.
J Biol Chem. 1996;271:15381–15385.
[14] Oquendo P, Hundt E, Lawler J, Seed B. CD36 di-
rectly mediates cytoadherence of Plasmodium falci-
parum parasitized erythrocytes. Cell. 1989;58:95–101.
[15] Steinberg D, Parthasarathy S, Carew TE, Khoo JC,
Witztum JL. Beyond cholesterol. Modiﬁcations of low-
density lipoprotein that increase its atherogenicity. N
Engl J Med. 1989;320:915–924.
[16] Fogelman AM, Van Lenten BJ, Warden C, Haberland
ME, Edwards PA, Macrophage lipoprotein receptors. J
Cell Sci. 1988;9(Suppl):135–149.
[17] Nicholson AC, Frieda S, Pearce A, Silverstein RL, Oxi-
dized LDL binds to CD36 on human monocyte-derived
macrophages and transfected cell lines. Evidence impli-
cating the lipid moiety of the lipoprotein as the binding
site. Arterioscler Thromb Vasc Biol. 1995;15:269–275.
[18] Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein
RL. Regulated expression of CD36 during monocyte-
to-macrophage diﬀerentiation: potential role of CD36
in foam cell formation. Blood. 1996;87:2020–2028.
[19] Nakata A, Nakagawa Y, Nishida M, et al. CD36, a
novel receptor for oxidized low-density lipoproteins, is
highly expressed on lipid-laden macrophages in human
atherosclerotic aorta. Arterioscler Thromb Vasc Biol.
1999;19:1333–1339.
[20] Puente Navazo MD, Daviet L, Ninio E, McGre-
gor JL. Identiﬁcation on human CD36 of a domain
(155-183) implicated in binding oxidized low-density
lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol.
1996;16:1033–1039.
[21] Nozaki S, Kashiwagi H, Yamashita S, et al. Re-
duced uptake of oxidized low density lipoproteins in
monocyte-derived macrophages from CD36-deﬁcient
subjects. JC l i nI n v e s t . 1995;96:1859–1865.
[22] Febbraio M, Podrez EA, Smith JD, et al. Targeted dis-
ruption of the class B scavenger receptor CD36 protects
against atherosclerotic lesion development in mice. J
Clin Invest. 2000;105:1049–1056.
[23] Febbraio M, Abumrad NA, Hajjar DP, et al. A null
mutation in murine CD36 reveals an important role
in fatty acid and lipoprotein metabolism. J Biol Chem.
1999;274:19055–19062.
[24] Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans
RM. PPARgamma promotes monocyte/macrophage
diﬀerentiation and uptake of oxidized LDL. Cell.
1998;93:241–252.
[25] Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans
RM. Oxidized LDL regulates macrophage gene expres-2:1 (2002) Expression of CD36 in apoE Knockout Mice 21
sion through ligand activation of PPARgamma. Cell.
1998;93:229–240.
[26] Chomczynski P, Sacchi N. Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-
chloroform extraction. Anal Biochem. 1987;162:156–
159.
[27] Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning:
A Laboratory Manual, 2nd ed., Cold Spring Harbor,
New York, NY: Cold Spring Harbor Laboratory; 1989.
[28] Huang JT, Welch JS, Ricote M, et al. Interleukin-
4-dependent production of PPAR-gamma ligands
in macrophages by 12/15-lipoxygenase. Nature.
1999;400:378–382.
[29] Wahle E, Keller W. The biochemistry of 3 -end cleav-
age and polyadenylation of messenger RNA precursors.
Annu Rev Biochem. 1992;61:419–440.
[30] Ibrahimi A, Bonen A, Blinn WD, et al. Muscle-speciﬁc
overexpression of FAT/CD36 enhances fatty acid oxi-
dation by contracting muscle, reduces plasma triglyc-
erides and fatty acids, and increases plasma glucose and
insulin. J Biol Chem. 1999;274:26761–26766.
[31] Neely JR, Rovetto MJ, Oram JF. Myocardial utiliza-
tion of carbohydrate and lipids. Prog Cardiovasc Dis.
1972;15:289–329.
[32] Tanaka T, Kawamura K. Isolation of myocardial mem-
brane long-chain fatty acid-binding protein: homology
with a rat membrane protein implicated in the binding
ortransportoflong-chainfattyacids.JMolCellCardiol.
1995;27:1613–1622.
[33] Watanabe K, Ohta Y, Toba K, et al. Myocardial CD36
expression and fatty acid accumulation in patients
with type I and II CD36 deﬁciency. Ann Nucl Med.
1998;12:261–266.
[34] Nozaki S, Tanaka T, Yamashita S, et al. CD36 me-
diates long-chain fatty acid transport in human my-
ocardium: complete myocardial accumulation defect of
radiolabeled long-chain fatty acid analog in subjects
with CD36 deﬁciency. M o lC e l lB i o c h e m . 1999;192:129–
135.
[35] Watanabe K, Toba K, Ogawa Y, et al. Hypertrophic car-
diomyopathy with type I CD36 deﬁciency. Jpn Circ J.
1998;62:541–542.
[36] Hwang EH, Taki J, Yasue S, et al. Absent myocar-
dial iodine-123-BMIPP uptake and platelet/monocyte
CD36 deﬁciency. JN u c lM e d . 1998;39:1681–1684.
[37] Shiratsuchi A, Kawasaki Y, Ikemoto M, Arai H, Nakan-
ishiY.RoleofclassBscavengerreceptortypeIinphago-
cytosis of apoptotic rat spermatogenic cells by Sertoli
cells. J Biol Chem. 1999;274:5901–5908.
[38] Reaven E, Zhan L, Nomoto A, Leers-Sucheta S, Azhar
S. Expression and microvillar localization of scavenger
receptor class B, type I (SR-BI) and selective cholesteryl
ester uptake in Leydig cells from rat testis. J Lipid Res.
2000;41:343–356.
[39] Yamamoto Y, Shimamoto K, Soﬁkitis N, Miyagawa I.
Eﬀects of hypercholesterolaemia on Leydig and Sertoli
cell secretory function and the overall sperm fertiliz-
ing capacity in the rabbit. Hum Reprod. 1999;14:1516–
1521.
[40] MoghadasianMH,NguyenLB,SheferS,McManusBM,
Frohlich JJ. Histologic, hematologic, and biochemical
characteristicsofapo E-deﬁcientmice:eﬀectsofdietary
cholesterol and phytosterols. Lab Invest. 1999;79:355–
364.
[41] Osuga J, Ishibashi S, Oka T, et al. Targeted disruption
of hormone-sensitive lipase results in male sterility and
adipocyte hypertrophy, but not in obesity. Proc Natl
Acad Sci USA. 2000;97:787–792.
[42] Yeaman SJ. Hormone-sensitive lipase—a multipurpose
enzyme in lipid metabolism. Biochim Biophys Acta.
1990;1052:128–132.
[43] Holst LS, Hoﬀmann AM, Mulder H, et al. Localization
of hormone-sensitive lipase to rat Sertoli cells and its
expression in developing and degenerating testes. FEBS
Lett. 1994;355:125–130.
[44] Holst LS, Langin D, Mulder H. Molecular cloning,
genomic organization, and expression of a testicu-
lar isoform of hormone-sensitive lipase. Genomics.
1996;35:441–447.
[45] Kraemer FB, Patel S, Saedi MS, Sztalryd C. Detection of
hormone-sensitive lipase in various tissues. I. Expres-
sion of an HSL/bacterial fusion protein and generation
of anti-HSL antibodies. J Lipid Res. 1993;34:663–671.
∗ Corresponding author.
Current address: Thrombosis Research Institute
(TRI), Emmanuel Kaye Building, Post-Genomics
Atherothrombosis Laboratory, Manresa Road, London
SW3 6LR, UK
E-mail: zibara@tri-london.ac.uk
Fax: +44 20 73518324; Tel: +44 20 73518314